ATIC anticorps (AA 310-550)
Aperçu rapide pour ATIC anticorps (AA 310-550) (ABIN1886357)
Antigène
Voir toutes ATIC AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 310-550
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 310 and 550 of ATIC
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- ATIC (5-Aminoimidazole-4-Carboxamide Ribonucleotide Formyltransferase/IMP Cyclohydrolase (ATIC))
-
Autre désignation
- ATIC
-
Sujet
-
This gene encodes a bifunctional protein that catalyzes the last two steps of the de novo purine biosynthetic pathway.The N-terminal domain has phosphoribosylaminoimidazolecarboxamide formyltransferase activity, and the C-terminal domain has IMP cyclohydrolase activity.A mutation in this gene results in AICA-ribosiduria.[provided by RefSeq]
Synonyms: AICAR, AICARFT, FLJ93545, IMPCHASE, PURH -
Poids moléculaire
- 65 kDa
-
ID gène
- 471
-
NCBI Accession
- NP_004035, NM_004044
Antigène
-